These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3517083)

  • 41. Adverse cutaneous reactions associated with fluoxetine strategy for reintroduction of this drug in selected patients.
    Leznoff A; Binkley KE; Joffee RT; Levitt A; Richter MA
    J Clin Psychopharmacol; 1992 Oct; 12(5):355-7. PubMed ID: 1479054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.
    Dominguez RA
    J Clin Psychiatry; 1992 Oct; 53 Suppl():56-9. PubMed ID: 1429485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug response assessed by the Modified Maudsley Obsessive-Compulsive Inventory.
    Dominguez RA; Jacobson AF; de la Gandara J; Goldstein BJ; Steinbook RM
    Psychopharmacol Bull; 1989; 25(2):215-8. PubMed ID: 2602515
    [No Abstract]   [Full Text] [Related]  

  • 44. A double blind study of imipramine versus zimelidine in treatment of obsessive compulsive neurosis.
    Prasad A
    Pharmacopsychiatry; 1984 Mar; 17(2):61-2. PubMed ID: 6233622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports.
    Warnock JK; Kestenbaum T
    Arch Dermatol; 1992 Dec; 128(12):1623-5. PubMed ID: 1456757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A fluoxetine-induced frontal lobe syndrome in an obsessive compulsive patient.
    Hoehn-Saric R; Harris GJ; Pearlson GD; Cox CS; Machlin SR; Camargo EE
    J Clin Psychiatry; 1991 Mar; 52(3):131-3. PubMed ID: 2005077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.
    Grady TA; Pigott TA; L'Heureux F; Hill JL; Bernstein SE; Murphy DL
    Am J Psychiatry; 1993 May; 150(5):819-21. PubMed ID: 8480832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What is the optimal dose of escitalopram for the treatment of obsessive-compulsive disorder? A naturalistic open-label study.
    Shim G; Park HY; Jang JH; Kim E; Park HY; Hwang JY; Kim SN; Jang GE; Kwon JS
    Int Clin Psychopharmacol; 2011 Sep; 26(5):284-90. PubMed ID: 21829108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind trial of fluoxetine in pathologic skin picking.
    Simeon D; Stein DJ; Gross S; Islam N; Schmeidler J; Hollander E
    J Clin Psychiatry; 1997 Aug; 58(8):341-7. PubMed ID: 9515971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluvoxamine in the treatment of obsessive compulsive disorder.
    Montgomery SA; Manceaux A
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():5-9. PubMed ID: 1355499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluoxetine treatment of obsessions and compulsions in patients with Tourette's syndrome.
    Riddle MA; Leckman JF; Hardin MT; Anderson GM; Cohen DJ
    Am J Psychiatry; 1988 Sep; 145(9):1173-4. PubMed ID: 3046386
    [No Abstract]   [Full Text] [Related]  

  • 52. Obsessive disorder with self-mutilation: a subgroup responsive to pharmacotherapy.
    Primeau F; Fontaine R
    Can J Psychiatry; 1987 Nov; 32(8):699-701. PubMed ID: 3500773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome.
    Kurlan R; Como PG; Deeley C; McDermott M; McDermott MP
    Clin Neuropharmacol; 1993 Apr; 16(2):167-72. PubMed ID: 8477412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.
    Hollander E; Soorya L; Chaplin W; Anagnostou E; Taylor BP; Ferretti CJ; Wasserman S; Swanson E; Settipani C
    Am J Psychiatry; 2012 Mar; 169(3):292-9. PubMed ID: 22193531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluoxetine: no association with suicidality in obsessive-compulsive disorder.
    Beasley CM; Potvin JH; Masica DN; Wheadon DE; Dornseif BE; Genduso LA
    J Affect Disord; 1992 Jan; 24(1):1-10. PubMed ID: 1545040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dosing strategies for antidepressant agents.
    Schatzberg AF
    J Clin Psychiatry; 1991 May; 52 Suppl():14-20. PubMed ID: 2030100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluoxetine-induced akathisia in male OCD patients.
    Friedman EH
    J Clin Psychiatry; 1990 May; 51(5):212. PubMed ID: 2378629
    [No Abstract]   [Full Text] [Related]  

  • 58. The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours: preliminary clinical experience.
    Eapen V; Trimble MR; Robertson MM
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):737-43. PubMed ID: 8843495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder.
    Go FS; Malley EE; Birmaher B; Rosenberg DR
    J Child Adolesc Psychopharmacol; 1998; 8(1):73-80. PubMed ID: 9639082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of fluoxetine on various subtypes of obsessive-compulsive disorder.
    Farnam A; Goreishizadeh MA; Farhang S
    Arch Iran Med; 2008 Sep; 11(5):522-5. PubMed ID: 18759519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.